Fluoxetine effects on sheepshead minnow (Cyprinodon variegatus) locomotor activity

Journal of Environmental Science and Health - Part B Pesticides, Food Contaminants, and Agricultural Wastes

Volumn 47, Issue 1, 2012, Pages 51-58

  Winder, Virginia L ^a   Pennington, Paul L ^a,b   Hurd, Mark W ^a,c   Wirth, Ed F ^a,b  

^a Department of Teacher Education and Department of Sociology and Anthropology   (United States)

^b CENTER FOR COASTAL ENVIRONMENTAL HEALTH AND BIOMOLECULAR RESEARCH   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Fluoxetine; locomotor activity; pharmaceuticals; serotonin; sheepshead minnow

Indexed keywords

ANTHROPOGENIC STRESSORS; CONFIDENCE LIMIT; CYPRINODON VARIEGATUS; ECOLOGICAL RESPONSE; FLUOXETINE; LINE CROSSINGS; LOCOMOTOR ACTIVITY; LOCOMOTOR BEHAVIOR; PHARMACEUTICAL PRODUCTS; SELECTIVE SEROTONIN REUPTAKE INHIBITOR; SEROTONIN; SHEEPSHEAD MINNOW; UNITED KINGDOM;

DRUG PRODUCTS; FOOD TECHNOLOGY; POLLUTION;

ANIMALS;

ANTHROPOGENIC EFFECT; DRUG; ECOLOGICAL IMPACT; HORMONE; INHIBITOR; LOCOMOTION; POLLUTION EXPOSURE; SUBLETHAL EFFECT; SURFACE WATER; TELEOST;

UNITED KINGDOM; UNITED STATES;

ANIMALIA; CYPRINODON VARIEGATUS;

FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ANIMAL; ARTICLE; CYPRINODONTIFORMES; DRUG EFFECT; ENVIRONMENTAL MONITORING; MOTOR ACTIVITY; PHYSIOLOGY; WATER POLLUTANT; WATER POLLUTION;

ANIMALS; ENVIRONMENTAL MONITORING; FLUOXETINE; KILLIFISHES; MOTOR ACTIVITY; SEROTONIN UPTAKE INHIBITORS; WATER POLLUTANTS, CHEMICAL; WATER POLLUTION, CHEMICAL;

EID: 84856597832     PISSN: 03601234     EISSN: 15324109     Source Type: Journal    
DOI: 10.1080/03601234.2012.607767     Document Type: Article

References (30)

1. Cleuvers, M. 2003. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol. Lett., 142(3): 185-194.
2. Halling-Sorensen, B., Nors Nielsen, S., Lanzky, P. F., Ingerslev, F., Holten Lutzhoft, H. C. and Jorgensen, S. E. 1998. Occurrence, fate and effects of pharmaceutical substances in the environment-A review. Chemosphere, 36(2): 357-393.
3. Santos, L. H.M.L.M., Araujo, A. N., Fachini, A., Pena, A., Delerue-Matos, C. and Montenegro, M. C.B.S.M. 2010. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment. Journal of Hazardous Materials, 175: 45-95.
4. Metcalfe, C. D., Koenig, B. G., Bennie, D. T., Servos, M., Ternes, T. A. and Hirsch, R. 2003. Occurrence of Neutral and Acidic Drugs in the Effluents of Canadian Sewage Treatment Plants. Environ. Toxicol. Chem., 22(12): 2872-2880.
5. Boyd, G. R., Reemtsma, H., Grimm, D. A. and Mitra, S. 2003. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Sci. Total Environ, 311: 135-149.
6. Brooks, B. W., Kevin Chambliss, C., Stanley, J. K., Ramirez, A., Banks, K. E., Johnson, R. D. and Lewis, R. J. 2005. Determination of Select Antidepressants in Fish from an Effluent-Dominated Stream. Environ. Toxicol. Chem, 24(2): 464-469.
7. Henry, T. B., Kwon, J.-W., Armbrust, K. L. and Black, M. C. 2004. Acute and Chronic Toxicity of Five Selective Serotonin Reuptake Inhibitors in Ceriodaphnia dubia. Environ. Toxicol. Chem, 23(9): 2229-2233.
8. Fryer, J. D. and Lukas, R. J. 1999. Antidepressants Noncompetitively Inhibit Nicotinic Acetylcholine Receptor Function. J. Neurochem, 72(3): 1117-1124.
9. Garcia-Colunga, J., Awad, J. N. and Miledi, R. 1997. Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac). Proc. Ntl. Acad. Sci., 94(5): 2041-2044.
10. 7 nicotinic receptors. Molec. Psych., 3: 350-355.
11. Rada, P. V., Mark, G. P. and Hoebel, B. G. 1993. In vivo modulation of acetylcholine in the nucleus accumbens of freely moving rats: I. Inhibition by serotonin. Brain Res., 619: 98-104.
12. Sebastine, I. M. and Wakeman, R. J. 2003. Consumption and environmental hazards of pharmaceutical substances in the UK. Process Safety and Environ. Prot., 81(4): 229-235.
13. Webb, S. F. 2001. "A data based perspective on the environmental risk assessment of human pharmaceuticals II - aquatic risk characterization". In Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks, Edited by: Kummerer, K. Berlin: Springer-Verlag.
14. Metcalfe, C. D., Miao, X.-S., Koenig, B. G. and Struger, J. 2003. Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the Lower Great Lakes, Canada. Environ. Toxicol. Chem., 22(12): 2881-2889.
15. Kolpin, D. W., Furlong, E. T., Meyer, M. T., Thurman, E. M., Zaugg, S. D., Barber, L. B. and Buxton, H. T. 2002. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A national reconnaissance. Environ. Sci. Technol., 36(6): 1202-1211.
16. Richards, S. M., Wilson, C. J., Johnson, D. J., Castle, D. M., Lam, M., Mabury, S. A., Sibley, P. K. and Solomon, K. R. 2004. Effects of pharmaceutical mixtures in aquatic microcosms. Environ. Toxicol. Chem., 23(4): 1035-1042.
17. Alanara, A. S., Winberg, S., Brannas, E., Kiessling, A., Hoglund, E. and Elofsson, U. 1998. Feeding behaviour, brain serotonergic activity levels, and energy reserves of the Arctic charr (Salvelinus alpinus) within a dominance hierarchy. Can. J. Zool., 76: 212-220.
18. Overli, O., Winberg, S., Damsgard, B. and Jobling, M. 1998. Food intake and spontaneous swimming activity in arctic charr (Salvelinus alpinus): Role of brain serotonergic activity and social interactions. Can. J. Zool., 76: 1366-1370.
19. Winberg, S., Carter, C. G., McCarthy, I. D., He, Z. Y., Nilsson, G. E. and Houlihan, D. F. 1993. Feeding rank and brain serotonergic activitiy in rainbow trout (Oncorhynchus mykiss). J. Exp. Biol., 179(1): 197-211.
20. Winberg, S., Myrberg, J. A.A. and Nilsson, G. E. 1996. Agonistic interactions affect brain serotonergic activity in an acanthopterygiian fish: The bicolor Damselfish (Pomacentrus partitus). Brain Beh. Evol., 48(4): 213-220.
21. Winberg, S., Nilsson, G. and Olsén, K. 1991. Social rank and brain levels of monoamines and monoamine metabolites in Arctic charr, Salvelinus alpinus (L.). J. Comp. Physiol. A Neuroethol. Sens. Neural Behav. Physiol., 168(2): 241-246.
22. Winberg, S., Winberg, Y. and Fernald, R. D. 1997. Effect of social rank on brain monoaminergic activity in a Cichlid Fish. Brain Beh. Evol., 49(4): 230-236.
23. Gaworecki, K. and Klaine, S. 2008. Behavioral and biochemical responses of hybrid striped bass during and after fluoxetine exposure. Aquatic Toxicology, 88(4): 207-213.
24. de Pedro, N., Pinillos, M. L., Valenciano, A. I., Alonso-Bedate, M. and Delgado, M. J. 1998. Inhibitory effect of serotonin on feeding behavior in Goldfish: Involvement of CRF. Peptides, 19(3): 505-511.
25. Perreault, H. A.N., Semsar, K. and Godwin, J. 2003. Fluoxetine treatment decreases territorial aggression in a coral reef fish. Physiol. Beh., 79(4-5): 719-724.
26. Winder, V. L., Sapozhnikova, Y., Pennington, P. L. and Wirth, E. F. 2009. Effects of fluoxetine exposure on serotonin-related activity in the sheepshead minnow (Cyprinodon variegatus) using LC/MS/MS detection and quantitation. Comp. Biochem. Physiol. C Toxicol. Pharmacol., 149(4): 559-565.
27. Bretaud, S., Lee, S. and Guo, S. 2004. Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease. Neurotoxicology and Teratology, 26(6): 857-864.
28. Clements, S. and Schreck, C. B. 2007. Chronic administration of fluoxetine alters locomotor behavior, but does not potentiate the locomotor stimulating effects of CRH in juvenile Chinook salmon (Oncorhynchus tshawytscha). Comp. Biochem. Physiol. Part A, 147: 43-49.
29. Norberg-King, T. J. 1993. A linear interpolation method for sublethal toxicity: The inhibition concentration (ICp) approach (Version 2.0). National Effluent Toxicity Assessment Center,
30. Airhart, M. J., Lee, D. H., Wilson, T. D., Miller, B. E., Miller, M. N. and Skalko, R. G. 2007. Movement disorders and neurochemical changes in zebrafish larvae after bath exposure to fluoxetine (Prozac). Neurotoxicology and Teratology, 29(6): 652-664.